Filing Details
- Accession Number:
- 0001209191-19-014804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-28 20:15:19
- Reporting Period:
- 2019-02-26
- Accepted Time:
- 2019-02-28 20:15:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636651 | Ovid Therapeutics Inc. | OVID | Pharmaceutical Preparations (2834) | 465270895 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654055 | Karen Bernstein | C/O Ovid Therapeutics Inc. 1460 Broadway, Suite 15044 New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-26 | 10,000 | $2.02 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.995 to 2.08 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
Billionaire Hedge Funds
